Cleared Traditional

K852361 - INTRAVENOUS INJECTION SET

K852361 is an FDA 510(k) clearance for INTRAVENOUS INJECTION SET, manufactured by The West Co., Inc.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 42-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1985
Decision
42d
Days
Class 2
Risk

K852361 is an FDA 510(k) clearance for the INTRAVENOUS INJECTION SET. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by The West Co., Inc. (Jersey Shore, US). The FDA issued a Cleared decision on July 16, 1985 after a review of 42 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all The West Co., Inc. devices

FDA 510(k) Submission Details - K852361

510(k) Number K852361 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 04, 1985
Decision Date July 16, 1985
Days to Decision 42 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
87d faster than avg
Panel avg: 129d · This submission: 42d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 514
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K852361.
CHURCHILL-H VENTED IV SET
K854437 · Churchill Corp. · Dec 1985
HUBOUT
K853287 · I M, Inc. · Oct 1985
CHURCHILL VENTED IV SET
K853204 · Churchill Corp. · Sep 1985
CONTROLLED RELEASE INFUSION SYSTEM(CRIS)
K852488 · Y · Jun 1985
NAMIC CONTRAST & FLUID DELIVERY SPIKES(VARIOUS)
K852140 · North American Instrument Corp. · May 1985
CORRECT FLO
K851299 · Norton Performance Plastics Corp. · May 1985